Literature DB >> 10428064

Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death.

S Yoshimura1, Y Banno, S Nakashima, K Hayashi, H Yamakawa, M Sawada, N Sakai, Y Nozawa.   

Abstract

Reduced glutathione (GSH) and N-acetylcysteine (NAC), but not other antioxidative or reducing agents, were found to inhibit cell death, both apoptosis and necrosis, induced by hypoxia in naive and nerve growth factor-differentiated PC12 cells. The level of intracellular total GSH decreased time-dependently during hypoxia, but exogenously added GSH prevented such a decrease in GSH. Pretreatment of cells with exogenous GSH or NAC resulted in inhibition of both neutral sphingomyelinase (SMase) activation and ceramide formation during hypoxia. In the in vitro assay system, neutral SMase activity was inhibited dose-dependently by GSH and NAC. Activation of caspase-3 induced by hypoxia was also inhibited by either GSH or NAC. NAC but not GSH inhibited caspase-3 activation induced by C2-ceramide. These results suggest that GSH protects cells from hypoxic injury by direct inhibition of neutral SMase activity and ceramide formation, resulting in inhibition of caspase-3 activation, and that NAC exerts an additional inhibitory effect(s) downstream of ceramide.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428064     DOI: 10.1046/j.1471-4159.1999.0730675.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

2.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.

Authors:  Roy G Cutler; Jeremiah Kelly; Kristin Storie; Ward A Pedersen; Anita Tammara; Kimmo Hatanpaa; Juan C Troncoso; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-15       Impact factor: 11.205

3.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

4.  Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione.

Authors:  S N Lavrentiadou; C Chan; T Kawcak; T Ravid; A Tsaba; A van der Vliet; R Rasooly; T Goldkorn
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

5.  Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells.

Authors:  S Noda; S Yoshimura; M Sawada; T Naganawa; T Iwama; S Nakashima; N Sakai
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 6.  Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology.

Authors:  Chiara Luberto; Jacqueline M Kraveka; Yusuf A Hannun
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 7.  The roles of neutral sphingomyelinases in neurological pathologies.

Authors:  Charles R Horres; Yusuf A Hannun
Journal:  Neurochem Res       Date:  2012-01-12       Impact factor: 3.996

8.  Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.

Authors:  E C Larsen; J F Hatcher; R M Adibhatla
Journal:  Neuroscience       Date:  2007-04-16       Impact factor: 3.590

Review 9.  Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.

Authors:  Arundhati Jana; Edward L Hogan; Kalipada Pahan
Journal:  J Neurol Sci       Date:  2009-01-14       Impact factor: 3.181

10.  Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation.

Authors:  Kristina Rutkute; Reto H Asmis; Mariana N Nikolova-Karakashian
Journal:  J Lipid Res       Date:  2007-08-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.